Biotech scientific marketing: expertise that speaks science, AI and compliance
Popularise without distorting, get cited by generative engines, stay compliant: what we do differently.
You are looking for an agency that truly understands what you make. Not a generalist agency that will turn your clinical pipeline into hollow slogans, but a team able to explain without betraying, optimize your visibility on generative engines and hold the regulatory line against the AI Act, the ANSM and the CNIL. This is precisely DigiObs's ground.
Contents
Explaining your science without distorting it
At most agencies, simplifying science means erasing nuance until the message is smooth and false. We do the opposite. Our job is to make a mechanism of action, a trial result or a preclinical data point understandable to an investor, a journalist or a prospect, while preserving the uncertainties that give science its credibility.
In practice, this means we publish nothing that a member of your scientific team would not validate. We cite sources, we distinguish what is demonstrated from what is promising, and we own the grey areas rather than erasing them. Technical audiences immediately spot content that is too polished. They trust what shows its reasoning. This rigor is what turns marketing content into a credibility argument with your stakeholders.
Being found on ChatGPT, Claude and Perplexity, not just on Google
Your future customers and investors no longer only type into a search bar. They ask questions to generative assistants, and these assistants recommend, or not, the companies they cite. GEO, Generative Engine Optimization, consists of structuring your content so that it is understood, cited and recommended by these engines.
We do not guess what works. We rely on concrete integrations (Semrush, the APIs of the main models) to measure your presence in generated answers, identify the questions on which your sector is decided, and produce content built to answer them. For a biotech or a deeptech, this visibility often arrives before Google's, on precise queries where your competitors are still absent. The first to occupy the conversational ground takes a lead that is hard to catch up.
Staying compliant as regulation tightens
For several quarters, healthcare marketing campaigns have been suspended for CNIL non-compliance on tracking and personalization. The AI Act now requires traceability and explainability for AI-generated content. Most agencies ignore these constraints or discover them after the fact.
We build them in from the design stage. Every piece of content produced with AI assistance keeps a usable audit trail, and our consent and tracking processes are designed for the healthcare framework, which is stricter than common law. For a compliance officer or a director of regulatory affairs, this changes the game: marketing stops being a risk to monitor and becomes a documented asset. You can communicate fast without exposing the company.
Three proofs rather than promises
Every engagement follows a written protocol: scientific framing with your team, source validation, production, compliance review, measurement. Nothing is left to improvisation, and at every step you know what has been validated and why.
Our writers and strategists include PhDs in life sciences and physics. When we discuss your technology, the person in front of you understands the substance. This is not a sales pitch, it is the condition for explaining science without error.
Improved average position on industry queries, appearances in generative engine answers, content picked up by the trade press. Our case studies detail the figures, the starting point and the path travelled.
They trust us
“DigiObs is the first agency I didn’t have to re-explain our mechanism of action to. The content was right from the first version.” (Founder, biotech startup raising funds)
“The compliance part saved us a considerable amount of time. Our regulatory affairs team validated the content without back-and-forth.” (Head of Scientific Communication, medtech)
- An AI-native scientific marketing agency, a team that brings science, GEO and compliance under one roof, and a methodology documented at every step.
Going further
Let's discuss your project
The fastest way to judge our work is to look at what we have produced for companies like yours. Then let's talk about yours.
Frequently asked questions
How does scientific marketing differ from classic B2B marketing?
Scientific marketing requires communicating technical data without betraying it, within a strict regulatory framework (ANSM, AI Act, CNIL healthcare rules) and in front of audiences that check. An oversimplified message destroys credibility instead of building it. It is a balancing act between clarity and rigor that demands a real understanding of the science.
Do your writers really understand my technology?
Yes. Our team includes people with doctorates in life sciences and physics. We frame every engagement with your in-house experts and publish nothing they have not validated. Understanding the substance is not optional with us.
How do you handle AI Act and CNIL compliance?
We build compliance in from the design stage, not as a correction. Content produced with AI assistance keeps an audit trail, and our tracking and consent set-ups respect the reinforced framework of healthcare marketing. Your regulatory affairs team receives documented, traceable deliverables.
What is GEO and why does it matter for a biotech?
GEO optimizes your presence in the answers of generative engines such as ChatGPT, Claude or Perplexity. Your prospects and investors ask their questions there. On specialized scientific topics, these engines recommend few players: taking that place early gives you a lasting advantage.
Do you work with early-stage startups?
Yes. We adapt the scope and pace to your stage, including ahead of a fundraising round, where a clear, verifiable science-plus-AI narrative weighs on investor confidence. We discuss it during the free consultation.
How long before we see results?
The first GEO content can appear in generative answers within a few weeks on niche queries. Classic SEO visibility and press pick-up settle in over a few months. Our case studies give concrete benchmarks by type of engagement.
Are you more expensive than a generalist agency?
We do not charge the lowest flat fee, because scientific rigor and compliance have a cost. On the other hand, false or non-compliant content costs far more: a suspended campaign, damaged credibility. We talk about it frankly during the consultation, budget included.
Let's talk about your project
Leading an innovative research project? Looking for a partner who can bring your idea to life beyond the scientific community?
Which type of engagement suits you best?